Morningstar

Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business — HBSS

SAN FRANCISCO, June 25, 2026 /PRNewswire/ -- Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock ...
Morningstar

EMBC Breaking Class Action Lawsuit: Embecta Sued for Securities Fraud after Insulin Pen Issues Lead to 57% Stock Drop – Investors Notified to Contact BFA Law

EMBC Breaking Class Action Lawsuit: Embecta Sued for Securities Fraud after Insulin Pen Issues Lead to 57% Stock Drop – Investors Notified to Contact BFA Law A securities fraud class action lawsuit ...
The Globe and Mail

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and ...
MD&M East

Weak Q1 Derails Diabetes Care Company Embecta

Earlier this year it appeared that Embecta, a diabetes care company that spun off from BD in 2022, was finally back on track after a rocky 2025. The Parsippany, NJ-based company’s fiscal ...